Magellan Health, Inc.

If you purchased Magellan Health, Inc. securities and would like to join the action, please click "Join This Action" below.

MAGELLAN MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF MAGELLAN HEALTH, INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – MGLN

January 4, 2021.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Magellan Health, Inc. (NASDAQ: MGLN) to Centene Corporation for $95.00 per share in cash is fair to Magellan shareholders.

The investigation concerns whether Magellan and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Magellan shareholders; (2) determine whether Centene is underpaying for Magellan; and (3) disclose all material information necessary for Magellan shareholders to adequately assess and value the merger consideration. On behalf of Magellan shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Scroll to Top